Evidence map›Paper›PMID 41652066›Full record

SynthesisInternational journal of colorectal disease2026

Colonic metastasis from breast carcinoma: A case report and systematic review of a rare clinical scenario.

Matteo Matteucci, Gisella Barone, Lorenza Zampino, Carla Codecà, Vincenza Paola Dinuzzi, Aurora Battista, Umberto Rivolta, MiMi Yen, Marco Galliano, Camillo Leonardo Bertoglio

Abstract readSystematic ReviewCase Reports
In one paragraph

Synthesis in International journal of colorectal disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Matteo MatteucciResidency in General Surgery, University of Milan, Milan, Italy. matteo.matteucci@unimi.it.
Gisella BaroneDepartment of General Surgery, Ospedale G. Fornaroli, ASST-Ovest Milanese, Magenta, Italy.
Lorenza ZampinoDepartment of General Surgery, Ospedale G. Fornaroli, ASST-Ovest Milanese, Magenta, Italy.
Carla CodecàDepartment of Oncology, Ospedale G. Fornaroli, ASST-Ovest Milanese, Magenta, Italy.
Vincenza Paola DinuzziDepartment of General Surgery, Ospedale G. Fornaroli, ASST-Ovest Milanese, Magenta, Italy.
Aurora BattistaResidency in General Surgery, University of Milan, Milan, Italy.
Umberto RivoltaDepartment of General Surgery, Ospedale G. Fornaroli, ASST-Ovest Milanese, Magenta, Italy.
MiMi YenResidency in General Surgery, University of Milan, Milan, Italy.
Marco GallianoDepartment of Oncology, Ospedale G. Fornaroli, ASST-Ovest Milanese, Magenta, Italy.
Camillo Leonardo BertoglioDepartment of General Surgery, Ospedale G. Fornaroli, ASST-Ovest Milanese, Magenta, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeColonic metastasis from breast cancer is extremely rare, with an incidence of only 0.1%. Diagnosis is often difficult and guidelines are not yet established. The aim of our review is investigating the latency from the primary tumor, the common symptoms, the diagnostic and therapeutic strategies and the role of surgery for this rare clinical scenario. MATERIALS: We report the case of a 57-year-old woman with multiple colonic metastasis from primary breast tumor, who underwent laparoscopic left hemicolectomy. A systematic review of 64 case reports was also conducted.

resultsLobular carcinoma is more frequently associated with gastro-intestinal (GI) metastasis than ductal carcinoma. The median age at diagnosis is 65.5 (IQR = 15) years with colonic metastases typically occurring after a median of 8 years (IQR = 13) from the primary tumor diagnosis. The most frequent symptoms are abdominal pain (34.4%), bowel habit changes (26.6%), and intestinal obstruction (9.4%). In 25% of cases, metastases were incidentally discovered during follow-up. The median disease-free survival was 12 months (IQR = 27.5). Thirteen studies reported death at a median of 12 months (IQR = 20), while 24 did not report follow-up data.

conclusionsThe poor prognosis is mainly due to long latency between primary diagnosis and metastasis onset, as well as to non-specific symptoms. Immuno-histochemical is crucial for diagnosis, although not sufficient to determine tumor origin definitively. Patients with history of breast cancer presenting with GI symptoms should undergo prompt endoscopic evaluation, although routine surveillance remains controversial. Surgery may be considered in selected cases, but systemic therapies remain the cornerstone of treatment.

Indexed as

Breast NeoplasmsColonic NeoplasmsFemaleHumansMiddle AgedBreast cancerCase reportColon metastasisHemicolectomyMetastatic breast tumor

Identifiers

PMID41652066
PMCPMC12881134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.